This article is more than 5 years old. Information may no longer be current.
New technologies allow customizable presbyopia correction
Click Here to Manage Email Alerts
NEW YORK — New presbyopia correcting technologies have allowed physicians to customize treatment plans specific to their patients, according to a speaker here.
Recent years have seen the IOL market expand and new options become available for presbyopic patients. Understanding the differences between these options, discussing them with patients while understanding what type of results those patients are looking for is paramount to success, Preeya K. Gupta, MD, said at OSN New York 2017.
“There are so many more options for presbyopia correction in our current day. It’s important to know all of the different presbyopia options,” she said.
The years 2016 and 2017 have been big years, she said: “Lots of new technology has been added to the presbyopia correction space.”
Clinicians should ask patients what their expectations are and what their needs are, and then evaluate the patient’s starting point, Gupta said.
Examining the patient for astigmatism, glaucoma or dry eye is the first step, but knowing the patient’s profession and vision demands is equally as important, she said.
“I think it’s really important to listen to your patients because matching the technology to what their needs are is sort of half the battle,” Gupta said. “Take all these bits and pieces of information and use that to determine what kind of technology you’re going to recommend.”
Patients who are not used to wearing reading glasses might be unsatisfied with an intermediate goal, while a hyperopic patient’s expectations will be different.
“Make sure you talk to your patients and familiarize yourself with the new technology because there’s a lot to learn out there,” Gupta said. – by Rebecca L. Forand
Reference:
Gupta PK. Correction of presbyopia with intraocular lenses: New options. Presented at: OSN New York 2017; Oct. 20-22, 2017; New York.
Disclosure: Gupta reports she is a consultant to Alcon, Allergan, Aurea, BioTissue, Johnson & Johnson Vision, NovaBay, Ocular Science, Shire, TearLab, TearScience and Carl Zeiss Meditec.